CHR. OLESEN SYNTHESIS A/S: Financial statements 2017
CVR: 33964870
Source: annual report 2017, Danish Business Authority
01/10/2016 – 30/09/2017
CHR. OLESEN SYNTHESIS A/S (CVR 33964870) has filed annual accounts for 2017. In 2017, the company reported a gross profit of EUR 1,201,543 and a net result of EUR -2,306,202 compared with EUR -3,223,972 the year before. Equity in the 2017 report amounted to EUR 5,099,868. The solvency ratio was 50.1%. The company had 42 employees in the financial year.
- Gross Profit
- EUR 1,201,543
- Profit/Loss
- EUR -2,306,202
- Equity
- EUR 5,099,868
- Total Assets
- EUR 10,180,455
- Employees
- 42
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 1.2M EUR | -2.3M EUR | 5.1M EUR | 42 |
| 2016 | - | -502K EUR | -3.2M EUR | 7.4M EUR | - |
| 2015 | - | 742K EUR | -1.4M EUR | 10.6M EUR | - |
| 2014 | - | -166K EUR | -2M EUR | -4.6M EUR | - |
| 2013 | - | -85 EUR | -1.5M EUR | -2.6M EUR | - |
Official annual report
Keep an eye on CHR. OLESEN SYNTHESIS A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
CHR. OLESEN SYNTHESIS A/S has published its annual report for 2016. Gross profit came to DKK -501,614, and the net result was DKK -3,223,972.
About CHR. OLESEN SYNTHESIS A/S
CHR. OLESEN SYNTHESIS A/S is a Danish company of the type Aktieselskab based in Hvidovre, founded in 2011. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The management consists of Thomas Michael Moestrup. The board consists of Jean-Francois Hilaire (chair), Joseph Nivaro and Thomas Michael Moestrup. The company is owned by Samfara/Bering Bidco Limited. The company has 97 employees (2026). In 2025, the company reported a gross profit of EUR 6,958,825 and a net result of EUR -2,299,046 compared with EUR 7,391,800 the year before. Equity in the 2025 report amounted to EUR -9,489,900.
